Drug Profile
NS 377
Latest Information Update: 28 Oct 1997
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class Neuroprotectants; Nootropics
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders; Neurological disorders
Most Recent Events
- 28 Oct 1997 Discontinued-Preclinical for Cognition disorders in Denmark (Unknown route)
- 28 Oct 1997 Discontinued-Preclinical for Neurological disorders in Denmark (Unknown route)
- 12 Mar 1997 No-Development-Reported for Cognition disorders in Denmark (Unknown route)